Antioxidants may promote cancer spread
Researchers have made a discovery that suggests cancer cells benefit more from antioxidants than normal cells, raising concerns about the use of dietary antioxidants by
Melanoma
Melanoma is a malignant tumour of melanocytes. Melanocytes predominantly occur in the skin but can be found elsewhere, especially the eye. The vast majority of melanomas originate in the skin.
Grapes and red wine may help to treat multiple types of cancer
Compound in grapes, red wine could help treat multiple types of cancer, study finds – A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment.
Lymphoseek to locate lymph nodes in breast cancer or melanoma patients
US FDA approves Lymphoseek to help locate lymph nodes in patients with certain cancers – breast cancer & melanoma – The U.S. Food and Drug Administration approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.
Aspirin may lower melanoma skin cancer risk
Aspirin may lower melanoma risk – Women who take aspirin have a reduced risk of developing melanoma – and that the longer they take it, the lower the risk. The findings of the new study suggest that aspirin’s anti-inflammatory effects may help protect against this type of skin cancer.
Intermittent dosing with vemurafenib may prolong lives of melanoma patients
Drug-Resistant Melanoma Tumors Shrink When Therapy Is Interrupted — ?Intermittent Dosing? Strategy in Lab Mice Suggests Simple Way to Help People with Late-Stage Melanoma – Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that may have important implications for the lives of patients with late-stage disease.
Colon cancer and rectal tumor constitute a single type of cancer
Study shows colon and rectal tumors constitute a single type of cancer — The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment – The pattern of genomic alterations in colon and rectal tissues is the same regardless of anatomic location or origin within the colon or the rectum, leading researchers to conclude that these two cancer types can be grouped as one, according to The Cancer Genome Atlas (TCGA) project’s large-scale study of colon and rectal cancer tissue specimens.
Painkillers like aspirin may protect against skin cancer
Commonly used painkillers may protect against skin cancer – Aspirin and other similar painkillers may help protect against skin cancer. The findings of new study indicate that skin cancer prevention may be added to the benefits of these commonly used medications.
Skin cancer melanoma rising in young adults
Mayo Clinic Study Finds Dramatic Rise in Skin Cancer in Young Adults — Researchers speculate indoor tanning bed use, childhood sunburns are key culprits – Even as the rates of some cancers are falling, Mayo Clinic is seeing an alarming trend: the dramatic rise of skin cancer, especially among people under 40. The incidence of melanoma has escalated, and young women are the hardest hit.
New melanoma drug doubles survival of skin cancer patients
Skin cancer drug hopes raised by study — Advanced melanoma drug nearly doubles survival time – Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
35 new drugs approved in 2011 in US
FDA: 35 innovative new drugs approved in fiscal year 2011 — Report shows quick approvals of safe and effective medicines occur in the United States before other countries – Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines for patients, like two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.